Salivary eicosanoid concentration in patients with Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 55, Issue 3, 1996, Pages 202-204

  Tishler, Moshe ^a   Yaron, Ilana ^a   Raz, Amiram ^b   Meyer, Frank A ^a   Yaron, Michael ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SALIVA LEVEL; SJOEGREN SYNDROME;

BIOLOGICAL MARKERS; DINOPROSTONE; EICOSANOIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; RADIOIMMUNOASSAY; SALIVA; SJOGREN'S SYNDROME; THROMBOXANE B2;

EID: 0029993729     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.3.202     Document Type: Article

References (16)

1. Talal N, Moutsopoulos K M, Kassan S S, eds. Sjögren's syndrome: clinical and immunological aspects. Berlin: Springer-Verlag, 1987.
2. Daniels T E. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 cases. Arthritis Rheum 1984; 27: 147-56.
3. Speight P M, Kawl A, Melson R D. Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome. Ann Rheum Dis 1992; 51: 499-502.
4. Baum B J, Fox P C. Chemistry of saliva. In: Talal N, Moutsopoulos H M, Kassan S S, eds. Sjögren's syndrome. Berlin: Springer-Verlag, 1987; 34-40.
5. Skopouli F N, Fox P C, Galanopoulou V, Atkinson J C, Jaffe E S, Moutsopoulos H M. T cell subpopulations in the labial salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol 1991; 18: 210-14.
6. Ogawa N, Dang H, Talal N. PCR analysis of cytokines produced in salivary glands of Sjögren's syndrome patients. In: Homma M, Sugai S, Tojo T, Miyasaka N, Akuzuki M, eds. Sjögren 's syndrome - state of the art. Amsterdam: Kugler, 1994; 103-10.
7. Rigas B, Lewis R A, Austen K F, et al. Identification and quantitation of arachidonic acid metabolic products in rabbit, rat and human saliva. Arch Oral Biol 1983; 28: 1031-5.
8. Rigas B, Levine L. Human salivary eicosanoids: circadian variation. Biochem Biophys Res Commun 1983; 115: 201-5.
9. Miller RJ, Mush M, Field M. Role of kinins and arachidonic acid metabolites in the control of intestinal ion transport. In: Brecht P, Garcey R P, Froehlich J C, Nicosia S, eds. Prostaglandins and membrane ion transport. New York: Raven Press, 1985; 173-8.
10. Ben Aryeh H, Spielman A, Szargel R, et al. Sialochemistry for the diagnosis of Sjögren's syndrome in xerostomic patients. Oral Surg 1981; 52: 487-90.
11. Vitali C, Bombardieri S, Moutsopoulos H M, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
12. Lefkowith J B, Flippo V, Sprecher H, Needleman P. Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency. J Biol Chem 1985; 260: 15736-44.
13. Schmidt M, Thorn J. Criteria for the salivary component of Sjögren's syndrome. A review. Clin Exp Rheumatol 1989; 7: 119-22.
14. Rigas B, Korenberg J R, Merill W W, Levine L. Prostaglandins E2 and F2a are elevated in saliva of cystic fibrosis patients. Am J Gastroenterol 1989; 84: 1408-12.
15. Nishino S, Ueno R, Ohishi K, Sakai T, Hayaishi O. Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry 1989; 146: 365-8.
16. Rigas B, Levine L. Concentrations of arachidonic acid metabolites in human mixed saliva are independent of flow rate. Arch Oral Biol 1983; 12: 1135-7.